Here we report a case of successful fiber optic laser treatment of lymphedema in a swollen arm post mastectomy. At the moment, this procedure has only anecdotal evidence to justify its use, but in our experience is a feasible, minimally invasive day-stay procedure which has been demonstrated to be safe and effective. Further nonhomogeneous case pooling and follow-up would enable guidelines and definite surgical protocols for its use to be implemented.
Introduction
Fiber optic laser surgery has been successfully introduced in several medical fields, especially in the oncological area. [1] [2] [3] [4] [5] In angiology, intravenous laser therapy is a dedicated venous procedure which can be used to remove an occlusion in the lumen of the saphenous system. 6 Over the last 3 years, we have gained considerable confidence in fiber optic technology, and have recently started to use this technique to assist in drainage of interstitial fluid to prevent fibrosis in patients with breast-cancer-related lymphedema. 7 Furthermore, a previous study used gallium arsenide (GaAs) laser therapy in postmastectomy patients, resulting in limb volume reduction and increases in shoulder mobility and grip strength. 8 Keeping the fiber optic laser positioned in a 150 µm cavity under the skin, the laser is then rotated upwards and activated to produce a series of short radial 10-15 cm tunnels within the normal lymphatic network in the skin, with the aim of diverting the volume of pooled interstitial fluid cephalad, redistributing the fluid in different directions by pressotherapy, 9 and inducing reabsorption of the fluid into the lymphatic vessels ( Figure 1 ). The procedure can be performed under local anesthesia with or without simple sedation, and with the aid of a skin cooling system. 10 Because it is an office or day-surgery procedure, it should not require any theatre time or prolonged hospital stay.
Case report
Twelve months ago, a 77-year-old woman, who had had a partial right mastectomy (biquadrantectomy) and lymphadenectomy for metastatic cancer, presented with progressive lymphedema of her right arm and an erysipelatous infection which was immediately treated with an aggressive combination regimen of teicoplanin ( This article was published in the following Dove Press journal: OncoTargets and Therapy 8 February 2013 Number of times this article has been viewed circumference measurements at presentation are reported in Table 1 . The patient signed an informed consent explaining the laser procedure in detail and its potential complications. She agreed to undergo laser treatment in view of progressive hardening and stiffening of her finger, wrist, and elbow. The procedure was performed in accordance with the tenets of the Declaration of Helsinki. Internal review board approval was obtained.
A 1062 nm 15 W Nd:YAG system (Evlaser ® , Elettronica Valseriana, Casnigo, Italy) was used. It was connected to a 150 µm diameter and 1 m long sterile fiber optic. Tramadol (Unitrama, 100 mg capsules; Angelini, Rome, Italy) and ketoprofen (Artrosilene, 160 mg/2 mL injectable solution; Dompé, L'Aquila, Italy) were administered by an intravenous line at the beginning of treatment, with an assistant cooling the arm using a frozen 10 cm 2 diameter plate. A bolus of 2% lidocaine (Lidocaina 100 mg/5 mL; Angelini) was injected to anesthetize the 2 cm 2 area of skin selected to introduce the fiber optic laser. Skin perforation was performed using a 21-gauge plastic venous catheter bearing a stainless steel stylet to aid introduction. Next, the stylet was withdrawn and the fiber optic laser was introduced into the lumen and advanced forward with its tip continuously emitting 150 J/cm 2 to perforate the fibrous tissue and create a channel during advancement along the entire length of her arm (Figure 2) . At the end of the procedure, the fiber optic tip was retrieved via the incision in the skin and redirected subdermally upwards into the normal lymphatic network, advanced for a shorter length (15-20 cm) in multiple radial directions to create shorter (15-30) tunnels where the lymph, which had been pushed upwards, could be temporarily pooled and then absorbed via the normal lymphatic network. The time taken to complete the procedure was about 1.5 hours. No stitches were required at the laser access site, and an elastic bandage was applied for 24 hours postoperatively. At 10-day follow-up, a decrease of arm and forearm circumference was observed ( Figure 3 ; Table 1 ). The procedure was repeated 2 weeks later in previously untreated regions of her right arm using the same protocol to achieve further volume reduction ( Figure 3 ) and thereby improve her arm function. After the second session, the patient's range of movement at her fingers, wrist, and elbow had improved.
Four month follow-up showed partial relapse of the treated segments consistent with hardness and stiffness. No further decrease in right arm circumference was observed, but the patient did not revert to her original clinical condition and asked for a third laser procedure because of the pain-free nature and low invasiveness of the method. After the procedure, the patient underwent three daily 30-minute sessions of manual lymph drainage and home pressotherapy twice daily for a week.
Discussion
This is the first report of the feasibility and safety of a novel procedure to reduce lymphedema using fiber optic laser to drill new channels for lymphatic drainage. In our experience, the procedure can be repeated up to 5-10 times in 6 months, depending on the patient's connective tissue reaction. Lymph drainage by manual massage and pressotherapy helps the drilled tunnels to become engorged with interstitial fluid and improves their patency, which counteracts occlusion by exceeding the outer-inner pressure ratio. The procedure described in this article is painless, if local anesthesia is fact, in our experience, it is very easy to drill the fibrotic septa that trap interstitial fluid in lymphedema by laser energy, but these passive newly formed lumina are prone to further fibrosis and obliteration. Therefore, our future goal will be to seed a layer of autologous endothelial cells recovered from short-segment phlebectomy into the newly formed channels or inject bone marrow-derived mesothelial stem cells to form a new endothelial surface, mimicking the patency and function of the normal lymphatic network. 13 Our fiber optic laser channel drilling approach with moderate beam power (150 J/cm 2 ) is very effective for rapid perforation of fibrous strands of lymphedematous tissue, without excessive heating or burning adjacent structures. In particular, when the fiber optic is withdrawn at the end of treatment, the interstitial fluid becomes cooler quickly since it is forced to diffuse into the new channels created by the laser. Active and passive rehabilitation exercise promotes continuous lymph flow into these structures, prolongs their patency and viability, and may be very efficacious if antifibrotic treatment is administered at the same time.
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Conclusion
Treatment of lymphedema using f iber optic laser is now a promising candidate treatment for helping pressotherapy rehabilitation to improve function and quality of life in patients affected by lymphedema. used at the skin access site and the arm surface is regularly cooled. 11 Obviously, multiple longitudinal channel drilling cannot be considered a radical management procedure for lymphedema. Because it achieves autonomous active lymphatic drainage, regular daily mechanical or manual pressotherapy 9 is required to keep the channels open and prevent further fibrotic reactions and obstruction of continuous lymph flow into the newly formed lumen. In our experience, it is mandatory to prepare a functional area in the normal dermis cephalad to the lymphedematous tissue in order to distribute the drained lymphatic volume recovered by daily pressotherapy through these short (15-20 cm) newly formed channels. Even if this step may damage the normal lymphatic network in the adjacent area, 12 it is necessary in order to facilitate uptake of fluid into normal lymphatic vessels. In submit your manuscript | www.dovepress.com
Dovepress
87
Fiber optic laser approach for lymphedematous syndrome
OncoTargets and Therapy
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/oncotargets-and-therapy-journal OncoTargets and Therapy is an international, peer-reviewed, open access journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment protocols employed to improve the management of cancer patients. The journal also focuses on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.
